» Articles » PMID: 36176280

The Epigenetic Aging, Obesity, and Lifestyle

Overview
Specialty Cell Biology
Date 2022 Sep 30
PMID 36176280
Authors
Affiliations
Soon will be listed here.
Abstract

The prevalence of obesity has dramatically increased worldwide over the past decades. Aging-related chronic conditions, such as type 2 diabetes and cardiovascular disease, are more prevalent in individuals with obesity, thus reducing their lifespan. Epigenetic clocks, the new metrics of biological age based on DNA methylation patterns, could be considered a reflection of the state of one's health. Several environmental exposures and lifestyle factors can induce epigenetic aging accelerations, including obesity, thus leading to an increased risk of age-related diseases. The insight into the complex link between obesity and aging might have significant implications for the promotion of health and the mitigation of future disease risk. The present narrative review takes into account the interaction between epigenetic aging and obesity, suggesting that epigenome may be an intriguing target for age-related physiological changes and that its modification could influence aging and prolong a healthy lifespan. Therefore, we have focused on DNA methylation age as a clinical biomarker, as well as on the potential reversal of epigenetic age using a personalized diet- and lifestyle-based intervention.

Citing Articles

Treating Metabolic Dysregulation and Senescence by Caloric Restriction: Killing Two Birds with One Stone?.

Russo L, Babboni S, Andreassi M, Daher J, Canale P, Del Turco S Antioxidants (Basel). 2025; 14(1).

PMID: 39857433 PMC: 11763027. DOI: 10.3390/antiox14010099.


Association between phenotypic age and mortality risk in individuals with obesity: a retrospective cohort study.

Huang Y, Zhou A, Huang Y, Wang Y, Liu X, Liu X Front Public Health. 2024; 12:1505066.

PMID: 39717032 PMC: 11663737. DOI: 10.3389/fpubh.2024.1505066.


Navigating Illumina DNA methylation data: biology versus technical artefacts.

Glaser S, Kretzmer H, Kolassa I, Schlesner M, Fischer A, Fenske I NAR Genom Bioinform. 2024; 6(4):lqae181.

PMID: 39703427 PMC: 11655293. DOI: 10.1093/nargab/lqae181.


The epigenetic modification of DNA methylation in neurological diseases.

Li L, Chen R, Zhang H, Li J, Huang H, Weng J Front Immunol. 2024; 15:1401962.

PMID: 39376563 PMC: 11456496. DOI: 10.3389/fimmu.2024.1401962.


Investigating the Relationship between Epigenetic Age and Cardiovascular Risk in a Population with Overweight/Obesity.

Marinello D, Favero C, Albetti B, Barbuto D, Vigna L, Pesatori A Biomedicines. 2024; 12(8).

PMID: 39200095 PMC: 11351200. DOI: 10.3390/biomedicines12081631.


References
1.
Fiorito G, Caini S, Palli D, Bendinelli B, Saieva C, Ermini I . DNA methylation-based biomarkers of aging were slowed down in a two-year diet and physical activity intervention trial: the DAMA study. Aging Cell. 2021; 20(10):e13439. PMC: 8520727. DOI: 10.1111/acel.13439. View

2.
Nevalainen T, Kananen L, Marttila S, Jylhava J, Mononen N, Kahonen M . Obesity accelerates epigenetic aging in middle-aged but not in elderly individuals. Clin Epigenetics. 2017; 9:20. PMC: 5310016. DOI: 10.1186/s13148-016-0301-7. View

3.
Cui D, Xu X . DNA Methyltransferases, DNA Methylation, and Age-Associated Cognitive Function. Int J Mol Sci. 2018; 19(5). PMC: 5983821. DOI: 10.3390/ijms19051315. View

4.
Correa-Burrows P, Burrows R, Albala C, Court F, Salech F, Sanhueza G . Multiple events case-control study in a prospective cohort to identify systemic, cellular, and molecular biomarkers of obesity-induced accelerated aging in 30-years-olds: the ObAGE study protocol. BMC Geriatr. 2022; 22(1):387. PMC: 9063300. DOI: 10.1186/s12877-022-03032-4. View

5.
Gardner J, Li S, Srinivasan S, Chen W, Kimura M, Lu X . Rise in insulin resistance is associated with escalated telomere attrition. Circulation. 2005; 111(17):2171-7. DOI: 10.1161/01.CIR.0000163550.70487.0B. View